Jci_page_head_homepage_01 Jci_page_head_homepage_02
Chiara Luberto, Beatriz Martinez-Mariño, Daniel Taraskiewicz, Benjamin Bolaños, Pasquale Chitano, Dena L. Toffaletti, Gary M. Cox, John R. Perfect, Yusuf A. Hannun, Edward Balish, Maurizio Del Poeta
Published in Volume 112, Issue 7
J Clin Invest. 2003; 112(7):1080–1094 doi:10.1172/JCI18309
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

(a) DD-RT-PCR in WT and GAL7:IPC1 10 strains using dT-A, -C, and -G with AP1 and AP2 primers. The number 1 denotes WT-glucose; 2, GAL7:IPC1-glucose; 3, WT-galactose; and 4, GAL7:IPC1-galactose. The black arrow indicates the App1 band, which is downregulated when Ipc1 is downregulated (no. 2) and upregulated when Ipc1 is upregulated (no. 4), with no significant changes in WT-glucose (no. 1) or WT-galactose (no. 3). (b) Ipc1 activity, RT-PCR, and Western blot of App1 in C. neoformans WT H99 and GAL7:IPC1 strains grown on glucose and galactose medium. APP1 expression is significantly regulated by Ipc1 modulation. Actin gene was used as a control. Two independent GAL7:IPC1 strains were used for RT-PCR (nos. 10 and 13).